Trials / Sponsors / Neurocentria, Inc.
Neurocentria, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Effica ADHD | Phase 2 | 2025-02-25 |
| Terminated | Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD Attention-Deficit/Hyperactivity Disorder (ADHD) | Phase 2 / Phase 3 | 2024-01-25 |
| Completed | Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD) ADHD | Phase 2 / Phase 3 | 2023-02-25 |
| Completed | Comparison of MMFS Dosages in Older Adults Anxiety, Depression, Sleep Quality | Phase 2 | 2018-07-23 |
| Completed | Efficacy and Safety of MMFS in Early AD Alzheimer Disease | Phase 2 | 2018-03-20 |